Cilgavimab, CAS 2420563-99-9

Product Description: Cilgavimab (AZD-1061; COV2-2130) is a human SARS-CoV-2-neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab (HY-P99556). Cilgavimab shows protective action on mouse models of SARS-CoV-2 infection[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Levin MJ, et al; PROVENT Study Group. Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19. N Engl J Med. 2022 Jun 9;386(23):2188-2200. /[2]Zost SJ, et al. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature. 2020 Aug;584(7821):443-449.

CAS Number: 2420563-99-9

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Infection

Solubility: 10 mM in DMSO

Target: SARS-CoV

• Artikelnummer: MEXHY-P99604-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99604-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated